THE RISK OF FINDING FOCAL CANCER (LESS THAN 3 MM) REMAINS HIGH ON RE-BIOPSY OF PATIENTS WITH PERSISTENTLY INCREASED PROSTATE SPECIFIC ANTIGEN BUT THE CLINICAL SIGNIFICANCE IS QUESTIONABLE

Abstract

In a repeat PSA based screening program sextant biopsies are of little or no value for predicting tumor volume.